Reading, MA, United States of America

David George Sanford

USPTO Granted Patents = 14 

 

 

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 79(Granted Patents)


Company Filing History:


Years Active: 2007-2024

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovations of David George Sanford

Introduction

David George Sanford is a prominent inventor based in Reading, Massachusetts. With an impressive portfolio of 14 patents, Sanford has made significant contributions to the field of medical therapeutics, particularly in targeted drug delivery systems.

Latest Patents

Among his latest innovations is a patent titled "FAP-activated therapeutic agents, and uses related thereto." This patent details the development of prodrugs of cytotoxic anthracyclines, including doxorubicin, which are specifically cleaved and activated by fibroblast activating protein (FAP). These prodrugs aim to enhance the targeted delivery of cytotoxic agents to tissues that express FAP, notably in various cancers and conditions such as fibrosis and inflammation. In addition to this, Sanford has provided methods for using these prodrugs in therapeutic settings, showcasing his commitment to advancing cancer treatment.

Career Highlights

Throughout his career, David George Sanford has collaborated with notable institutions such as Bach Biosciences, LLC and Tufts College. His innovative work has bolstered advancements in the medical field, particularly in cancer therapeutics, through his focused research on drug design and development.

Collaborations

Sanford’s collaborative efforts include working alongside esteemed colleagues, including William W. Bachovchin and Hung-sen Lai. Together, they have explored cutting-edge solutions to address critical medical challenges, fostering innovation in their respective fields.

Conclusion

In conclusion, David George Sanford stands out as a dedicated inventor whose work in FAP-activated therapeutic agents represents a significant leap in the medical innovation landscape. His extensive patent portfolio and partnerships with leading organizations underscore his influence and commitment to improving health outcomes. As research in targeted therapies continues to evolve, Sanford's contributions remain vital to the advancement of cancer treatment and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…